GSA Capital Partners’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30,749
| Closed | -$212K | – | 2231 |
|
|
2025
Q1 | $212K | Buy |
+30,749
| New | +$212K | 0.02% | 1376 |
|
|
2023
Q2 | – | Sell |
-103,742
| Closed | -$159K | – | 2019 |
|
|
2023
Q1 | $159K | Buy |
103,742
+23,874
| +30% | +$36.6K | 0.02% | 1299 |
|
|
2022
Q4 | $134K | Buy |
+79,868
| New | +$134K | 0.02% | 1274 |
|
|
2022
Q3 | – | Sell |
-19,176
| Closed | -$32K | – | 1932 |
|
|
2022
Q2 | $32K | Sell |
19,176
-35,113
| -65% | -$58.6K | ﹤0.01% | 1307 |
|
|
2022
Q1 | $134K | Buy |
+54,289
| New | +$134K | 0.02% | 1251 |
|
|
2021
Q2 | – | Sell |
-19,886
| Closed | -$186K | – | 1641 |
|
|
2021
Q1 | $186K | Sell |
19,886
-39,335
| -66% | -$368K | 0.03% | 928 |
|
|
2020
Q4 | $284K | Sell |
59,221
-3,547
| -6% | -$17K | 0.05% | 772 |
|
|
2020
Q3 | $252K | Buy |
+62,768
| New | +$252K | 0.04% | 861 |
|
|
2018
Q4 | – | Sell |
-13,700
| Closed | -$59K | – | 1803 |
|
|
2018
Q3 | $59K | Sell |
13,700
-38,200
| -74% | -$165K | ﹤0.01% | 1584 |
|
|
2018
Q2 | $193K | Buy |
+51,900
| New | +$193K | 0.01% | 1542 |
|